Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Medtronic
Citi
Harvard Business School
Moodys
Cerilliant
Julphar
Mallinckrodt
Johnson and Johnson
AstraZeneca

Generated: October 22, 2017

DrugPatentWatch Database Preview

DESOXYN Drug Profile

« Back to Dashboard

What is the patent landscape for Desoxyn, and when can generic versions of Desoxyn launch?

Desoxyn is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in DESOXYN is methamphetamine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.

Summary for Tradename: DESOXYN

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list11
Clinical Trials: see list3
Patent Applications: see list4,844
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DESOXYN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare
DESOXYN
methamphetamine hydrochloride
TABLET, EXTENDED RELEASE;ORAL005378-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
DESOXYN
methamphetamine hydrochloride
TABLET;ORAL005378-002Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
Recordati Rare
DESOXYN
methamphetamine hydrochloride
TABLET, EXTENDED RELEASE;ORAL005378-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
DESOXYN
methamphetamine hydrochloride
TABLET, EXTENDED RELEASE;ORAL005378-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
Healthtrust
McKinsey
Fish and Richardson
Express Scripts
Cipla
Mallinckrodt
Cerilliant
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot